PharmCAT.NET

Biostatistics, pharmacokinetics and clinical trials.

  • Home page
  • Blog
  • Contacts
  • Agreement & Confidentiality

IBM SPSS Extension: R Project PowerTOST library

Posted on December 31, 2018December 31, 2018 by frozencat

IBM SPSS Extension PowerTOST R Project library. Syntax command: POWERTOST.

Version: 1.0.0

Functions:

  • power.TOST
  • sampleN.TOST
  • CVfromCI

Дизайны:

  • parallel
  • 2×2
  • 2x2x4

Скачать/Download

GitHUB: https://github.com/PharmCat/SPSSPowerTOST

Categories: Blog, SPSS

Post navigation

Next Post:

Recent Posts

  • IBM SPSS + R Project: Confidence intervals for proportions, independent groups
  • IBM SPSS Extension: R Project PowerTOST library

Галерея

IMG-20170805-WA0004
20180129 155949
20180815 144119
DJI 0050
20180202 123629
IMG-20170806-WA0007
  • Advisory Letters
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-22 By FDA
  • Application Submissions Guidances
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-10-21 By FDA
  • MOLOOCO dba Ourlyard - Online Advisory Letter
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • FDA Provides Update to Health Care Professionals About Risk of Inadvertent Intrathecal (Spinal) Administration of Tranexamic Acid Injection
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • Reviews of Pediatric Studies Conducted under BPCA and Pediatric assessments conducted under PREA from 2012 – present
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • Guangxi Yulin Pharmaceutical Group Co. Ltd. - 710422 - 09/30/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 8, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-21
  • Human medicines European public assessment report (EPAR): Voriconazole Accord, voriconazole, Date of authorisation: 16/05/2013, Revision: 22, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-21
  • Foshan Yiying Hygiene Products Co., Ltd. - 715548 - 10/10/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • All American Wellness - 715991 - 09/09/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • www.usmedschoice.com - 716055 - 10/06/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • Acme United Corporation - 712324 - 10/10/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 12, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-21
  • BRS Analytical Services, LLC - 711133 - 09/17/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
  • Timeline of Selected FDA Activities and Significant Events Addressing Substance Use and Overdose Prevention
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-21 By FDA
Older posts
Theme: Scaffold by Danny Cooper.